Cysticidal activity of antifungals against different genotypes of Acanthamoeba

Antimicrob Agents Chemother. 2014 Sep;58(9):5626-8. doi: 10.1128/AAC.02635-14. Epub 2014 Jul 7.

Abstract

Antifungal drugs have been proposed as a novel treatment for Acanthamoeba keratitis. The cysticidal activity of several antifungal compounds was tested against different genotypes of culture collection and clinical isolates of Acanthamoeba. Only voriconazole and posaconazole were found to be cysticidal, with no differences in activity observed between clinical and culture collection isolates.

MeSH terms

  • Acanthamoeba / drug effects*
  • Acanthamoeba / genetics
  • Acanthamoeba Keratitis / drug therapy*
  • Amebiasis / drug therapy*
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Cysts / drug therapy*
  • Cysts / parasitology
  • Humans
  • Parasitic Sensitivity Tests
  • Triazoles / pharmacology
  • Triazoles / therapeutic use
  • Voriconazole / pharmacology
  • Voriconazole / therapeutic use

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole
  • Voriconazole